Our R&D Center is dedicated to creating high-quality pharmaceutical intermediates, impurity standards, and deuterium-labeled compounds that meet global regulatory expectations, including IP, USP, and BP.
With advanced synthesis capabilities and rigorous quality control, we deliver compounds that pharmaceutical companies worldwide trust for their critical development programs.
We manufacture and supply a diverse portfolio of intermediates used across multiple drug development pathways. Each compound is formulated with exceptional purity and stored under controlled conditions to preserve its physical and chemical integrity. From milligram quantities to bulk-scale production, we deliver reliable intermediates tailored to your project needs.
Our team specializes in the synthesis of stable-labeled APIs and metabolites, including deuterium- and 13C-labeled compounds. With deep expertise in placing labels at the most stable positions, we ensure minimal exchange and maximum assay reliability.
We support the industry with comprehensive impurity profiling and custom impurity synthesis, offering A-to-Z impurity solutions from milligrams to multi-gram scale.
Precision chemistry meeting global pharmaceutical standards
Tailored synthesis services for pharmaceutical intermediates with flexible scaling from milligrams to bulk production.
Expertise in deuterium and 13C-labeled compound synthesis with optimal label placement for maximum stability.
Comprehensive impurity profiling and reference standard preparation meeting USP, BP, and IP requirements.
